“Evaluations of tumor acidosis, hypoxia and vascular perfusion with molecular imaging”

Hosted by the Mallinckrodt Institute of Radiology (MIR) 

Background: Dr. Mark “Marty” Pagel directs the Contrast Agent Molecular Engineering Laboratory (CAMEL), which focuses on molecular imaging research at the pre-clinical and clinical levels to interrogate biomarkers of the tumor microenvironment. Research studies in CAMEL are very multidisciplinary, spanning chemistry, biochemistry, cell & molecular biology, cancer biology, immunology, biomedical engineering, medical physics, and radiology. Due to these multidisciplinary activities, CAMEL provides a great environment for collaborations and for training researchers who are interested in molecular imaging of cancer.

For inquiries contact Robert Massa.